Who
Luba Greenwood
Director
Company insider
Files Form 4 as: Director, IN8bio; Director, Traws Pharma; Director, Ernexa Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $999
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 29 Jul 2021
- Last trade
- 9 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —63,150 at $0.00 | filing |
| 19 Dec 2024filed 23 Dec 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —39,449 at $0.00 | filing |
| 16 Sep 2024filed 17 Sep 2024 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —164,000 at $0.00 | filing |
| 12 Jun 2024filed 14 Jun 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,650 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 16 Aug 2022filed 18 Aug 2022 | INAB IN8bioBiotechnology | SEC FORM 4 Bought | $999526 at $1.90 | filing |
| 1 Jun 2022filed 23 Sep 2022 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 1 Jun 2022filed 14 Jun 2022 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,500 at $0.00 | filing |
| 8 Dec 2021filed 10 Dec 2021 | ERNA Ernexa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,000 at $0.00 | filing |
| 29 Jul 2021filed 2 Aug 2021 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.